» Articles » PMID: 21251810

Switching TGFβ from a Tumor Suppressor to a Tumor Promoter

Overview
Publisher Elsevier
Specialties Biology
Genetics
Date 2011 Jan 22
PMID 21251810
Citations 119
Authors
Affiliations
Soon will be listed here.
Abstract

TGFβ acts as a potent tumor suppressor and tumor promoter in a context dependent manner. Tumor suppressive functions include inhibition of cell proliferation, induction of apoptosis and regulation of autophagy. As tumors develop they switch their response to TGFβ and utilise this factor as a potent promoter of cell motility, invasion, metastasis and tumor stem cell maintenance. These multifactorial tumor influencing actions of TGFβ involve regulation of an increasing number of signal transduction pathways employing a diverse range of signaling molecules. Understanding the molecular mechanisms of how tumor cells respond to TGFβ and switch their response to this cytokine during disease progression is vital for both the development and the informed use of potentially powerful TGFβ targeted therapeutics.

Citing Articles

Association of NR0B1 with Malignant Phenotypes in Esophageal Squamous Cell Carcinoma Through Modulation of p53-Independent Cell-Cycle Regulation.

Iizuka A, Kanda M, Sato Y, Shimizu D, Umeda S, Tanaka H Ann Surg Oncol. 2025; .

PMID: 40080367 DOI: 10.1245/s10434-025-17109-y.


() Is a SMAD3-Dependent TGF-β Target Gene That Promotes Clonogenicity and Correlates with Poor Prognosis in Breast Cancer.

Strathearn L, Spender L, Schoenherr C, Mason S, Edwards R, Blyth K Cells. 2024; 13(18.

PMID: 39329715 PMC: 11429573. DOI: 10.3390/cells13181530.


Fully-automated production of [Ga]Ga-Trivehexin for clinical application and its biodistribution in healthy volunteers.

Wang B, Jiang Y, Zhu J, Wu H, Wu J, Li L Front Oncol. 2024; 14:1445415.

PMID: 39156699 PMC: 11327152. DOI: 10.3389/fonc.2024.1445415.


Circular RNA circWNK1 inhibits the progression of gastric cancer via regulating the miR-21-3p/SMAD7 axis.

Dai T, Qiu S, Gao X, Zhao C, Ge Z, Yang Y Cancer Sci. 2024; 115(3):974-988.

PMID: 38287200 PMC: 10921006. DOI: 10.1111/cas.16067.


RAC1b Collaborates with TAp73α-SMAD4 Signaling to Induce Biglycan Expression and Inhibit Basal and TGF-β-Driven Cell Motility in Human Pancreatic Cancer.

Ungefroren H, Reimann J, Konukiewitz B, Braun R, Wellner U, Lehnert H Biomedicines. 2024; 12(1).

PMID: 38255305 PMC: 10813112. DOI: 10.3390/biomedicines12010199.